Cancer cells expressed high levels of ligands CXCL1, CXCL2, CXCL3, and CXCL8, signaling to the receptors CXCR1 and CXCR2 expressed by neutrophils (Fig. 6c). This evidence concerns the gene CXCR1 and cancer.